“Synthetic formulation of psilocybin developed by Compass Pathways.”

“Compass Pathways' fully synthetic formulation of psilocybin, with robust patent protection until 2038, being tested in phase three trials.”

“Synthetic psilocybin formulation developed by Compass Pathways.”